Literature DB >> 9779453

Inhibition of [3H]dopamine translocation and [3H]cocaine analog binding: a potential screening device for cocaine antagonists.

M E Reith1, C Xu, F I Carroll, N H Chen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9779453     DOI： 10.1016/s0076-6879(98)96019-0

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN： 0076-6879            Impact factor:   1.600


× No keyword cloud information.
  3 in total

1.  CTDP-32476: A Promising Agonist Therapy for Treatment of Cocaine Addiction.

Authors:  Zheng-Xiong Xi; Rui Song; Xia Li; Guan-Yi Lu; Xiao-Qing Peng; Yi He; Guo-Hua Bi; Siyuan Peter Sheng; Hong-Ju Yang; Haiying Zhang; Jin Li; Mark Froimowitz; Eliot L Gardner
Journal:  Neuropsychopharmacology       Date:  2016-08-18       Impact factor: 7.853

2.  Gene therapy restores dopamine transporter expression and ameliorates pathology in iPSC and mouse models of infantile parkinsonism.

Authors:  Joanne Ng; Serena Barral; Carmen De La Fuente Barrigon; Gabriele Lignani; Fatma A Erdem; Rebecca Wallings; Riccardo Privolizzi; Giada Rossignoli; Haya Alrashidi; Sonja Heasman; Esther Meyer; Adeline Ngoh; Simon Pope; Rajvinder Karda; Dany Perocheau; Julien Baruteau; Natalie Suff; Juan Antinao Diaz; Stephanie Schorge; Jane Vowles; Lucy R Marshall; Sally A Cowley; Sonja Sucic; Michael Freissmuth; John R Counsell; Richard Wade-Martins; Simon J R Heales; Ahad A Rahim; Maximilien Bencze; Simon N Waddington; Manju A Kurian
Journal:  Sci Transl Med       Date:  2021-05-19       Impact factor: 19.319

3.  The effect of alpha-synuclein knockdown on MPP+ toxicity in models of human neurons.

Authors:  Timothy M Fountaine; Lara Lourenco Venda; Nicholas Warrick; Helen C Christian; Patrik Brundin; Keith M Channon; Richard Wade-Martins
Journal:  Eur J Neurosci       Date:  2008-11-21       Impact factor: 3.386
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.